ArticleProbiotics and antimicrobial proteins2026
Antibacterial and Antifungal Potential of Hermetia illucens Hemolymph Contained-Peptides.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Antimicrobial Peptides, Bacteriocins and Mycocins as Natural Antimicrobials: Applications in Food Safety, Agriculture and Healthcare.Antibiotics (Basel, Switzerland) · 2026Review
- Article
- Molecular Diversity, Structure-Function Relationship, Mechanism of Action, and Transformative Potential of Black Soldier Fly Antimicrobial Peptides Against Multidrug-Resistant Pathogens.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Antimicrobial peptides (AMPs) constitute a chemically and structurally heterogeneous family of molecules produced by a wide range of living organisms, including plants, fish, amphibians, mammals, and insects. Their expression is particularly high in hosts frequently exposed to microorganisms, where AMPs play a key role in innate immune responses. Insects represent one of the richest natural sources of AMPs. Over their long evolutionary history, they have developed a highly efficient immune system with AMPs playing a central role in defense against pathogens, enabling them to colonize various habitats. In recent years, interest in AMPs has significantly increased due to the emergence of antibiotic resistance, positioning these peptides as potential therapeutic alternatives for treating infections caused by multi-resistant pathogens. In this study, we investigated the antimicrobial activity of peptide fractions extracted from the hemolymph of Hermetia illucens larvae (Diptera, Stratiomyidae), an insect known for its high expression of AMPs. Larvae were injected separately with either Escherichia coli (Gram-negative) or Micrococcus flavus (Gram-positive), and hemolymph was collected 24 h post-infection, as well as from uninfected larvae. Antimicrobial activity was assessed through microbiological assays, including both agar diffusion tests and microdilution assays. Results demonstrated significant activity against pathogenic bacterial strains, including antibiotic-resistant ones. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) were determined for each experimental condition. MIC values ranged from 0.023 to 0.375 µg·µL⁻
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.